Category Specific RSS

infant formula

Bubs enrols 400th infant in its US clinical trials to get baby formula approval

Under its old business model, the number 4 would typically never be marketed to their major customers but under the…

10 months ago

Softer infant formula demand in Middle East, China and EU squeeze Clover’s profits

In 2023, global birth rates dipped by 1.15% per 1000 people, with significant declines noted in the EU (5.9%) and…

1 year ago

Bubs presents its rebound plan after bitter breakup with former CEO and Chairman

A bitter boardroom spat has left baby formula company Bubs Australia (ASX: BUB) scrambling to undertake serious damage control following…

2 years ago

Synlait receives permit renewal to supply baby formula to the Chinese market

China has emerged as a hotspot for baby formula export from Australia and New Zealand. Imported baby formula holds a…

2 years ago

Bubs Australia founder and CEO forced out for alleged failure to comply with board directions

Just a month after Bubs Australia (ASX: BUB) announced that executive chairman Dennis Lin would be removed from the business,…

2 years ago

China revenue falls 66% as Bubs reports declining sales

The infant formula market has more than doubled over the past decade. But not all companies have managed to keep…

2 years ago